515 related articles for article (PubMed ID: 28984195)
1. MD-Miner: a network-based approach for personalized drug repositioning.
Wu H; Miller E; Wijegunawardana D; Regan K; Payne PRO; Li F
BMC Syst Biol; 2017 Oct; 11(Suppl 5):86. PubMed ID: 28984195
[TBL] [Abstract][Full Text] [Related]
2. A novel individualized drug repositioning approach for predicting personalized candidate drugs for type 1 diabetes mellitus.
Zheng H
Stat Appl Genet Mol Biol; 2019 Jul; 18(5):. PubMed ID: 31287801
[TBL] [Abstract][Full Text] [Related]
3. Inferring new indications for approved drugs via random walk on drug-disease heterogenous networks.
Liu H; Song Y; Guan J; Luo L; Zhuang Z
BMC Bioinformatics; 2016 Dec; 17(Suppl 17):539. PubMed ID: 28155639
[TBL] [Abstract][Full Text] [Related]
4. Computational Drug Repositioning with Random Walk on a Heterogeneous Network.
Luo H; Wang J; Li M; Luo J; Ni P; Zhao K; Wu FX; Pan Y
IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(6):1890-1900. PubMed ID: 29994051
[TBL] [Abstract][Full Text] [Related]
5. Drug Repositioning to Accelerate Drug Development Using Social Media Data: Computational Study on Parkinson Disease.
Zhao M; Yang CC
J Med Internet Res; 2018 Oct; 20(10):e271. PubMed ID: 30309833
[TBL] [Abstract][Full Text] [Related]
6. Diffusion mapping of drug targets on disease signaling network elements reveals drug combination strategies.
Xu J; Regan-Fendt K; Deng S; Carson WE; Payne PRO; Li F
Pac Symp Biocomput; 2018; 23():92-103. PubMed ID: 29218872
[TBL] [Abstract][Full Text] [Related]
7. A network based approach to drug repositioning identifies plausible candidates for breast cancer and prostate cancer.
Chen HR; Sherr DH; Hu Z; DeLisi C
BMC Med Genomics; 2016 Jul; 9(1):51. PubMed ID: 27475327
[TBL] [Abstract][Full Text] [Related]
8. Computational drug repositioning using meta-path-based semantic network analysis.
Tian Z; Teng Z; Cheng S; Guo M
BMC Syst Biol; 2018 Dec; 12(Suppl 9):134. PubMed ID: 30598084
[TBL] [Abstract][Full Text] [Related]
9. A Systematic Framework for Drug Repositioning from Integrated Omics and Drug Phenotype Profiles Using Pathway-Drug Network.
Jadamba E; Shin M
Biomed Res Int; 2016; 2016():7147039. PubMed ID: 28127549
[TBL] [Abstract][Full Text] [Related]
10. DrugNet: network-based drug-disease prioritization by integrating heterogeneous data.
MartÃnez V; Navarro C; Cano C; Fajardo W; Blanco A
Artif Intell Med; 2015 Jan; 63(1):41-9. PubMed ID: 25704113
[TBL] [Abstract][Full Text] [Related]
11. Network-Based Drug Repositioning: Approaches, Resources, and Research Directions.
Alaimo S; Pulvirenti A
Methods Mol Biol; 2019; 1903():97-113. PubMed ID: 30547438
[TBL] [Abstract][Full Text] [Related]
12. Mining heterogeneous network for drug repositioning using phenotypic information extracted from social media and pharmaceutical databases.
Yang CC; Zhao M
Artif Intell Med; 2019 May; 96():80-92. PubMed ID: 31164213
[TBL] [Abstract][Full Text] [Related]
13. A computational method for clinically relevant cancer stratification and driver mutation module discovery using personal genomics profiles.
Wang L; Li F; Sheng J; Wong ST
BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S6. PubMed ID: 26099165
[TBL] [Abstract][Full Text] [Related]
14. Repositioning drugs by targeting network modules: a Parkinson's disease case study.
Yue Z; Arora I; Zhang EY; Laufer V; Bridges SL; Chen JY
BMC Bioinformatics; 2017 Dec; 18(Suppl 14):532. PubMed ID: 29297292
[TBL] [Abstract][Full Text] [Related]
15. Time-resolved evaluation of compound repositioning predictions on a text-mined knowledge network.
Mayers M; Li TS; Queralt-Rosinach N; Su AI
BMC Bioinformatics; 2019 Dec; 20(1):653. PubMed ID: 31829175
[TBL] [Abstract][Full Text] [Related]
16. Computational drugs repositioning identifies inhibitors of oncogenic PI3K/AKT/P70S6K-dependent pathways among FDA-approved compounds.
Carrella D; Manni I; Tumaini B; Dattilo R; Papaccio F; Mutarelli M; Sirci F; Amoreo CA; Mottolese M; Iezzi M; Ciolli L; Aria V; Bosotti R; Isacchi A; Loreni F; Bardelli A; Avvedimento VE; di Bernardo D; Cardone L
Oncotarget; 2016 Sep; 7(37):58743-58758. PubMed ID: 27542212
[TBL] [Abstract][Full Text] [Related]
17. Network mirroring for drug repositioning.
Park S; Lee DG; Shin H
BMC Med Inform Decis Mak; 2017 May; 17(Suppl 1):55. PubMed ID: 28539121
[TBL] [Abstract][Full Text] [Related]
18. DrPOCS: Drug Repositioning Based on Projection Onto Convex Sets.
Wang YY; Cui C; Qi L; Yan H; Zhao XM
IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(1):154-162. PubMed ID: 29993698
[TBL] [Abstract][Full Text] [Related]
19. Using Prognosis-Related Gene Expression Signature and Connectivity Map for Personalized Drug Repositioning in Multiple Myeloma.
Zhu FX; He YC; Zhang JY; Wang HF; Zhong C; Wang XT
Med Sci Monit; 2019 May; 25():3247-3255. PubMed ID: 31048671
[TBL] [Abstract][Full Text] [Related]
20. Drug repositioning using drug-disease vectors based on an integrated network.
Lee T; Yoon Y
BMC Bioinformatics; 2018 Nov; 19(1):446. PubMed ID: 30463505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]